cagrisema cagrilintide semaglutide phase 3 results 2024 2025 Presenters to provide first look at data from REIMAGINE trials of cagrilintide/semaglutide for type 2 diabetes management Semaglutide, a glucagon-like peptide-1 (GLP-1)
Pay in 4 interest-free payments of $5.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
00125-7/asset/c8ecd4ec-8b7c-48e1-bb82-1c56292e9cbf/main.assets/gr3_lrg.jpg)










01751-7/asset/6309d074-38cb-40bc-984b-962ca1dbd6df/main.assets/gr2b_lrg.jpg)



![PDF] Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial](https://figures.semanticscholar.org/a9800c8f0dc40d6d18a09ab6d2f14e71a42af380/4-Figure1-1.png)









